1. 102327229 一种匹多莫德干混悬剂
CN
22.06.2016
A61K 9/14 Loading...
A61K 9/14
Loading...
102011000290215
海南康芝药业股份有限公司
洪丽萍
A61K 9/14
Loading...
本发明提供一种匹多莫德干混悬剂，由匹多莫德和辅料组成，所述的辅料为填充剂、助悬剂和矫味剂，其特征在于所述的矫味剂为草莓香精、柠檬酸三钠、氯化钠和阿司帕坦的混合物。本发明通过选用特定的矫味剂，不仅可以很好地解决了匹多莫德干混悬剂的口感问题，而且令人意外地发现，还具有起效快，有助于匹多莫德干混悬剂的稳定性的效果。
2. 104147013 一种抗耐药菌组合物及其制法
CN
19.11.2014
A61K 31/546 Loading...
A61K 31/546
Loading...
201410450370.5
海南康芝药业股份有限公司
洪江游
A61K 31/546
Loading...
本发明公开了一种抗耐药菌组合物及其制备方法。本发明的抗耐药菌组合物是由头孢他啶五水合物62.67%～75%，他唑巴坦20.9%～25%，增溶剂0%～7.3%，稳定保护剂0%～8.11%组成，但不包括头孢他啶五水合物75%，他唑巴坦25%制备得到。本发明的组合物具有时序性给药、长效给药的特点，对目前大多数耐药菌敏感，通过377例临床试验证明，对呼吸道感染和泌尿系感染与对应的单药及最常用有、最效的对照，具有显著疗效且副作用等不良反应少的优点，符合网络药理学的药物开发理念，是对抗细菌耐药性治疗的有效手段。
3. 203935425 一种儿童给药装置
CN
12.11.2014
A61J 7/00 Loading...
A61J 7/00
Loading...
201320659118.6
海南康芝药业股份有限公司
纪嘉琳
A61J 7/00
Loading...
本实用新型公开了一种儿童给药装置，其包括具有中通进药孔的安抚奶嘴、可插设于所述进药孔的吸管或滴管，所述安抚奶嘴包括吮吸头、防护挡板。通过提供安抚奶嘴给儿童吮吸，使其处于娱悦状态，然后将插于安抚奶嘴的进药孔处的滴管中装有的药液挤出而灌入儿童口中，吮吸过程就把药液喝下，在儿童愉悦的状态下完成给药，增加儿童用药的顺应性，保证用药剂量的准确。
4. 203419272 一种儿童药品分剂量生产装置及药品分剂量包装体
CN
05.02.2014
B65B 9/067 Loading...
B65B 9/067
Loading...
201320516310.X
海南康芝药业股份有限公司
洪丽萍
B65B 9/067
Loading...
本实用新型公开了一种儿童药品分剂量生产装置及药品分剂量包装体，是由排列式定量系统、成型热合系统和切割系统组成，排列式定量系统设置按照分剂量要求的不同而设置相应的给料列式。本实用新型克服了药品因粉尘污染而造成热合质量不好和袋口变小袋内气体不能逸出阻止物料进袋的问题，提高了儿童药品分剂量精确度和灵活性，还具备生产制作简单、易于加工、一机多用和符合量身订制儿童药等优点。
5. 103536538 Expansive pellet for effectively masking taste and preparation method thereof
CN
29.01.2014
A61K 9/16 Loading...
A61K 9/16
Loading...
201310499993.7
海南康芝药业股份有限公司
洪江游
A61K 9/16
Loading...
The invention provides an expansive pellet for effectively masking taste. The expansive pellet is composed of medicine serving as an active ingredient and pharmaceutic adjuvant. The pellet provided by the invention is composed of the following components in percentage by weight: 0.15-10% of medicine raw material, 15-85% of filler, 12-80% of expanding agent, 0.15-0.6% of plasticizer, 0.5-0.8% of lubricant and 0.8-1.5% of adhesive. The yield of the taste masking pellet prepared by the invention is high and can reach 75-90%; and the production process is simple. The particle diameter of the prepared pellet is 300-800 microns, the pellet is poured into warm water before being taken, and the pellet immediately expands and continuously increases. The expansion volume can reach 100-700% to generate a good visual effect. The pellet is taken after expanding, so that the taste is smooth, the pellet has certain elasticity to be beneficially swallowed and can effectively mask the bitter taste and unpleasant taste of the medicine so as to easily eliminate the rejection feeling of the elders, the patients having swallowing difficulty and especially children on the medicine with bitter taste and unpleasant taste, and the pellet is particularly suitable for medicine with bitter taste and unpleasant taste. The method disclosed by the invention is simple and is suitable for industrial production.
6. 103520471 一种中药合剂的苦味掩盖剂
CN
22.01.2014
A61K 36/8968 Loading...
A61K 36/8968
Loading...
201310492329.X
海南康芝药业股份有限公司
洪丽萍
A61K 36/8968
Loading...
本发明公开了一种中药合剂的苦味掩盖剂，所述的中药合剂按重量份计由中药材地黄180份，麦冬160份，玄参260份，连翘315份和黄芩315份制成，该苦味掩盖剂由纽甜0.2～0.8份，甘草浸膏4～12份组成。相对于该合剂现有的其他苦味掩盖剂具有匹配度高，用量少，口感舒适，稳定性高等优点。不但使患者服药的顺从性得到了较大程度的改善，也为产品带来较高的附加值。
7. 103407603 Fractional dose production method for children drugs, production device and products
CN
27.11.2013
B65B 9/067 Loading...
B65B 9/067
Loading...
201310370169.1
海南康芝药业股份有限公司
洪丽萍
B65B 9/067
Loading...
The invention discloses a fractional dose production method for children drugs, a production device and products. The production device is formed by an arrangement type quantitative system, a forming thermal sealing system and a cutting system; the arrangement type quantitative system is provided with corresponding feeding column types according to different fractional dose requirements; the problems that the thermal sealing quality of the drugs is poor due to dust pollution and gases inside bags cannot be escaped due to reduction of bag openings prevents materials entering into the bags are solved. The production device has the advantages of improving accuracy and flexibility of the fractional dose of the children drugs, being simple in production, easy to process and multifunctional, confirming to requirements of specific children drugs and the like.
8. 103301462 治疗病毒疾病的成分和方法
CN
18.09.2013
A61K 45/00 Loading...
A61K 45/00
Loading...
201310077649.9
海南康芝药业股份有限公司
艾德铭
A61K 45/00
Loading...
本发明涉及治疗病毒疾病的成分和方法。首次揭示了一种P2X受体拮抗剂的新用途，用于制备一种治疗病毒感染疾病的组合物。所述的P2X受体拮抗剂通过抑制病毒发挥预防或治疗手足口病的作用。
9. 203143272 一种儿童安全的家庭药盒
CN
21.08.2013
B65D 50/02 Loading...
B65D 50/02
Loading...
201320034601.5
海南康芝药业股份有限公司
洪江游
B65D 50/02
Loading...
本实用新型提供一种儿童安全的家庭药盒，由盒盖（1）和盒身（7）组成；所述盒盖（1）由外盖（2）和内盖（4）组成。所述外盖（2）上设置咬合片（3），内盖（4）设置咬合口（6），咬合口（6）的两端设计了凸点（5）；所述内盖（4）的盖口设置螺纹（8），盒身（7）上设置凸出的圆孔（9），该圆孔（9）外面有螺纹（10）；内盖（4）与圆孔（9）的大小互相匹配，使螺纹（8）与螺纹（10）互相拧紧结合。本实用新型设计的盒盖较大，儿童的手不易握住，设计了外盖（2）和内盖（4），两者之间有咬合口，无论顺反旋转，都无法打开盒，以防止儿童自行打开药盒，乱服药物发生意外。本实用新型结构简单，方便携带与使用，更有利于儿童安全。有较大的应用价值。
10. 103083283 氯雷他定膜状制剂
CN
08.05.2013
A61K 9/70 Loading...
A61K 9/70
Loading...
201310046849.8
上海现代药物制剂工程研究中心有限公司
陈芳
A61K 9/70
Loading...
本发明公开了一种氯雷他定膜状制剂，包括条状膜带和负载在其上的治疗有效量的活性药物氯雷他定；所述条状膜带，包括酸性条状膜带和碱性条状膜带，所述酸性条状膜带和碱性条状膜带连成一体，并相互间隔设置；所述酸性条状膜带，以高水溶性高分子成膜材料为主体，以膜带重量计，含有1～20％的酸性剂；所述碱性条状膜带，以高水溶性高分子成膜材料为主体，以膜带重量计，含有1～20％碱性剂；所述氯雷他定负载在酸性条状膜带上，或者负载在碱性条状膜带上，或者同时负载在酸性条状膜带和碱性条状膜带上。本发明遇水后成为泡腾膜，麻痹嗅觉而掩味，并可加速溶。
11. 102552871 一种鞣酸蛋白酵母咀嚼片及其生产方法
CN
11.07.2012
A61K 38/02 Loading...
A61K 38/02
Loading...
201110413044.3
海南康芝药业股份有限公司
凌日金
A61K 38/02
Loading...
本发明提供一种鞣酸蛋白酵母咀嚼片及其生产方法。所述的鞣酸蛋白酵母咀嚼片包括素片和包衣层，其中所述的素片，每1000片中：鞣酸蛋白100.0g，干酵母100.0g，蔗糖286.5g，甜菊素0.8g，鲜奶香精2.0g，浊奶香精2.0g，微分硅胶3.0g，硬脂酸镁1.5g，羟丙甲基纤维素4.2g。本发明通过特定配比和种类的辅料生产出味甜且有香气的产品，而且溶出度高，具有吸收快，性能稳定，肠道残留少的特点；服用方法不需用水，容易提高患者特别是儿童及吞咽困难患者的服药依从性，特别意想不到的是咀嚼可以产生胃酶，提前进入消化程序，提高了药物的生物利用度。
12. 102526084 Roxithromycin ambroxol tablet
CN
04.07.2012
A61K 31/7048 Loading...
A61K 31/7048
Loading...
201110413045.8
海南康芝药业股份有限公司
王稳奇
A61K 31/7048
Loading...
The invention provides a roxithromycin ambroxol tablet, which consists of the following components in parts by weight: 150 parts of roxithromycin, 30 parts of ambroxol hydrochloride, 60 parts of microcrystalline cellulose, 20 parts of sodium starch glycolate, 6 parts of poloxamer, an appropriate amount of bonding agent and optionally existing flow aid and lubricating agent. In the invention, the roxithromycin ambroxol tablet is prepared by adopting specified auxiliary materials and auxiliary material proportion, and particularly, microcrystalline cellulose, carboxyrnethyl starch sodium and poloxamer are taken as a filler, a disintegrating and a solubilizer, so that the using amount of the auxiliary materials is greatly reduced, cost is greatly lowered, the tablet weight is light, convenience is brought to taking, the dissolution of active ingredients is ensured, and the bioavailability is increased. The roxithromycin ambroxol tablet has remarkable advantages.
13. 102327229 一种匹多莫德干混悬剂
CN
25.01.2012
A61K 9/14 Loading...
A61K 9/14
Loading...
201110290215.8
海南康芝药业股份有限公司
洪丽萍
A61K 9/14
Loading...
本发明提供一种匹多莫德干混悬剂，由匹多莫德和辅料组成，所述的辅料为填充剂、助悬剂和矫味剂，其特征在于所述的矫味剂为草莓香精、柠檬酸三钠、氯化钠和阿司帕坦的混合物。本发明通过选用特定的矫味剂，不仅可以很好地解决了匹多莫德干混悬剂的口感问题，而且令人意外地发现，还具有起效快，有助于匹多莫德干混悬剂的稳定性的效果。
14. 102327243 一种匹多莫德咀嚼片
CN
25.01.2012
A61K 9/20 Loading...
A61K 9/20
Loading...
201110290213.9
海南康芝药业股份有限公司
凌日金
A61K 9/20
Loading...
本发明提供一种匹多莫德咀嚼片，其由匹多莫德和辅料组成，其中所述的辅料为稀释剂、矫味剂、润滑剂和粘合剂，其特征在于所述的矫味剂为碳酸氢钠、阿司帕坦和草莓香精。本发明令人意外地发现，通过特定的矫味剂，匹多莫德咀嚼片不仅具有口感好，而且还令人意外地具有起效快，生物利用度高效果。
15. 102327233 二巯丁二酸颗粒剂
CN
25.01.2012
A61K 9/16 Loading...
A61K 9/16
Loading...
201110290211.X
海南康芝药业股份有限公司
王稳奇
A61K 9/16
Loading...
本发明提供一种二巯丁二酸固体制剂，特别是一种二巯丁二酸颗粒剂，其由二巯丁二酸和辅料制成，其中所述的辅料为掩味剂和选自以下组中的一种或两种以上：稀释剂、崩解剂、助悬剂、甜味剂、粘合剂，其特征在于所述的掩味剂为β-环糊精和液体奶油香精，并且是通过包括如下步骤的方法制成颗粒剂：二巯丁二酸和液体奶油香精混匀后，再加入β-环糊精进行混匀。本发明的二巯丁二酸颗粒剂，采用新颖的掩味技术，将二巯丁二酸的蒜样臭味有效掩盖，而且本发明制剂具有令人愉快的芳香味和水果味，更适宜儿童服用。
16. 102327234 一种消旋卡多曲干混悬剂
CN
25.01.2012
A61K 9/16 Loading...
A61K 9/16
Loading...
201110290214.3
海南康芝药业股份有限公司
王稳奇
A61K 9/16
Loading...
本发明提供一种消旋卡多曲干混悬剂，由如下组分制成：消旋卡多曲1份，甘露醇1～3份，羧甲纤维素钠5～9份，蔗糖150～200份，泊洛沙姆1～6份和微粉硅胶1～6份。其不仅具有良好的稳定性等制剂学效果，而且通过特定的矫味剂，本发明的消旋卡多曲干混悬剂不仅解决了不良口感问题，而且还惊奇地发现具有起效快，生物利用度高的效果，更好地应用于临床，特别是作为儿科药用制剂。
17. 102000050 Nimesulide medicine composition for improving dissolution performance and preparation method thereof
CN
06.04.2011
A61K 31/18 Loading...
A61K 31/18
Loading...
201010526114.1
Hainan Kangzhi Pharmaceutical Co., Ltd.
Hong Jiangyou
A61K 31/18
Loading...
The invention provides a nimesulide medicine composition for improving dissolution performance and a preparation method thereof. The medicine composition in the invention comprises the following components in weight percentage: 1%-30% of nimesulide, 5%-30% of dispersing agent (at least one kind of liquid polyethylene glycol), 60%-85% of diluent (one or more of microcrystalline cellulose, lactose and starch), 1%-10% of silicon dioxide, 2%-20% of disintegrating agents (carboxymethyl starch sodium) and 0.1%-5.0% of adhesives (hydroxypropyl methylcellulose). The dissolution degree of the nimesulide medicine composition can reach above 90% within 5-10 minutes, and even 100%, thus the nimesulide medicine composition is different from the conventional solid composition of various medicines; and the nimesulide medicine composition improves the bioavailability of the nimesulide, is beneficial to clinical rapid fever abatement or pain killing and has high application value.
18. 101816672 Composition containing roxithromycin and ambroxol and preparation method thereof
CN
01.09.2010
A61K 31/7048 Loading...
A61K 31/7048
Loading...
201010155106.0
Hainan Honz Pharmaceutical Co., Ltd.
Chen Yunfei
A61K 31/7048
Loading...
The invention discloses a composition containing roxithromycin and ambroxol and a preparation method thereof. The composition consists of roxithromycin and ambroxolhydrochloride which serve as active ingredients, a flavoring agent and an adhesive, and is made into particles. In preparation, the roxithromycin and the ambroxolhydrochloride are made into particles respectively and then the particles are mixed. In the invention, due to the special composition formula and the separate particle making method, the strong bitter tastes of the roxithromycin and the ambroxolhydrochloride are relieved, the stability of the particles are improved, and the composite is suitable for patients having difficulties in swallowing, particularly children.
19. 101669913 Levocetirizine dihydrochloride granule and preparation and detection methods thereof
CN
17.03.2010
A61K 9/16 Loading...
A61K 9/16
Loading...
200910093094.0
Hainan Honz Pharmaceutical Co., Ltd.
Hong Jiangyou
A61K 9/16
Loading...
The invention discloses a levocetirizine dihydrochloride granule and preparation and detection methods thereof. The specification of the levocetirizine dihydrochloride particle is 2.5 mg, and milk sugar is used as filling agent. The levocetirizine dihydrochloride granule dispenses with the process of disintegration of tablets and capsules in a human body, the degree of dispersion in the human bodyis superior to the tablets and the capsules, and the absorption is faster than the tablets, the capsules and dispersible tablets; and the flowability, the dispersibility and the adhesiveness are better than the dispersible tablets, the granule is convenient to take, the mouthfeel is easier to adjust, and the curative effect of the medicine can be guaranteed to be better played.
20. 101485673 Roxithromycin and ambroxol hydrochloride dispersible tablets
CN
22.07.2009
A61K 31/7048 Loading...
A61K 31/7048
Loading...
200910008869.X
Hainan Honz Pharmaceutical Co., Ltd.
Hong Jiangyou
A61K 31/7048
Loading...
The invention relates to a roxithromycin ambroxol dispersing tablet, which comprises the following components in percentage by weight: 50 to 60 percent of roxithromycin, 10 to 20 percent of ambroxol hydrochloride, 18 to 25 percent of filling agent, 10 to 15 percent of disintegrant, 0.1 to 1 percent of adhesive, and 1 to 5 percent of lubricating agent, wherein the filling agent is microcrystalline cellulose, and the disintegrant is crosslinked polyvidone. The roxithromycin ambroxol dispersing tablet has the advantages of small tablet weight, simple process, low production cost and good safety, and has better therapeutic effect when being clinically applied to upper respiratory tract infections of human bodies.
21. 101422441 Nimesulide sustained-release tablet and preparation method thereof
CN
06.05.2009
A61K 9/22 Loading...
A61K 9/22
Loading...
200810181030.1
Hainan Honz Pharmaceutical Co., Ltd.
Hong Jiangyou
A61K 9/22
Loading...
The invention provides a Nimesulide sustained-release tablet and a preparation method thereof. The Nimesulide sustained-release tablet is prepared by Nimesulide, skeleton sustained-release material, a bond and a lubricant. The invention is characterized in that the skeleton sustained-release material is a mixture of compressible starch and hydroxypropyl methylcellulose with the weight ratio of 1 : 1; moreover, the weight ratio of the Nimesulide : the compressible starch : the hydroxypropyl methylcellulose is 2 : 1 : 1; wherein, the preferable viscidity range of the hydroxypropyl methylcellulose is 20 to 4000 mpa.s. The Nimesulide sustained-release tablet can be slowly released to maintain more stable blood medicine concentration and longer action time; the Nimesulide sustained-release tablet taken before sleeping can appear peaking effect in the morning, achieve the best clinic treatment target and have better medicament economy advantage.

